John Nuss Ventyx Biosciences, Inc. (VTYX) insider trading activity

John Nuss is CHIEF SCIENTIFIC OFFICER of Ventyx Biosciences, Inc.. Currently has a direct ownership of 264,998 shares of VTYX, which is worth approximately $455,796. The most recent transaction as insider was on Apr 02, 2024, when has been sold 1,651 shares (Common Stock) at a price of $5.4 per share, resulting in proceeds of $8,915. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 265K

0% 3M change

8.24% 12M change

Total Value Held $455,796

John Nuss Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 02 2024	SELL Open market or private sale	$8,915 $5.4 p/Share	1,651 Reduced 0.62%	264,998 Common Stock
Mar 28 2024	BUY Exercise of conversion of derivative security	-	4,531 Added 1.67%	266,649 Common Stock
Dec 20 2023	SELL Open market or private sale	$37,371 $2.12 p/Share	17,628 Reduced 6.3%	262,118 Common Stock
Dec 17 2023	BUY Exercise of conversion of derivative security	-	34,931 Added 11.1%	279,746 Common Stock
Oct 03 2023	SELL Open market or private sale	$303,300 $30.33 p/Share	10,000 Reduced 3.92%	244,815 Common Stock
Oct 03 2023	BUY Exercise of conversion of derivative security	$39,300 $3.93 p/Share	10,000 Added 3.78%	254,815 Common Stock
Sep 05 2023	SELL Open market or private sale	$328,300 $32.83 p/Share	10,000 Reduced 3.92%	244,815 Common Stock
Sep 05 2023	BUY Exercise of conversion of derivative security	$2,000 $0.2 p/Share	10,000 Added 3.78%	254,815 Common Stock
Aug 03 2023	SELL Open market or private sale	$357,400 $35.74 p/Share	10,000 Reduced 3.92%	244,815 Common Stock
Aug 03 2023	BUY Exercise of conversion of derivative security	$2,000 $0.2 p/Share	10,000 Added 3.78%	254,815 Common Stock
Jul 03 2023	SELL Open market or private sale	$737,200 $36.86 p/Share	20,000 Reduced 7.55%	244,815 Common Stock
Jul 03 2023	BUY Exercise of conversion of derivative security	$4,000 $0.2 p/Share	20,000 Added 7.02%	264,815 Common Stock
Jun 05 2023	SELL Open market or private sale	$344,700 $34.47 p/Share	10,000 Reduced 3.92%	244,815 Common Stock
Jun 05 2023	BUY Exercise of conversion of derivative security	$2,000 $0.2 p/Share	10,000 Added 3.78%	254,815 Common Stock
May 03 2023	SELL Open market or private sale	$385,700 $38.57 p/Share	10,000 Reduced 3.92%	244,815 Common Stock
May 03 2023	BUY Exercise of conversion of derivative security	$2,000 $0.2 p/Share	10,000 Added 3.78%	254,815 Common Stock
Apr 03 2023	SELL Open market or private sale	$996,600 $33.22 p/Share	30,000 Reduced 10.92%	244,815 Common Stock
Apr 03 2023	BUY Exercise of conversion of derivative security	$6,000 $0.2 p/Share	30,000 Added 9.84%	274,815 Common Stock
Dec 22 2022	SELL Open market or private sale	$436,597 $31.61 p/Share	13,812 Reduced 5.34%	244,815 Common Stock
Dec 17 2022	BUY Exercise of conversion of derivative security	-	34,931 Added 11.9%	258,627 Common Stock
Dec 13 2022	SELL Open market or private sale	$1,201,200 $34.32 p/Share	35,000 Reduced 13.53%	223,696 Common Stock
Dec 05 2022	SELL Open market or private sale	$1,432,500 $28.65 p/Share	50,000 Reduced 16.2%	258,696 Common Stock

John Nuss

CHIEF SCIENTIFIC OFFICER

Encinitas, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VTYX shares.

Notify only if

Value

Insider Trading

Get notified when an Ventyx Biosciences, Inc. insider buys or sells VTYX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ventyx Biosciences, Inc.

Track Activities on VTYX

Account